Purchase Order N3239816P0353
Award Date
8/11/16
Potential Completion Date
8/31/17
Potential Value
$93K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Valencia, CA 91355, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $1,897 firm fixed-price purchase order is for labor hours (CLIN 9236439) with a period of performance through September 29, 2019. Qiagen is an established provider of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare...
This federal contract award is for the purchase of a "QIACUBE FULL AGREEMENT" by the Bureau of Medicine and Surgery (BUMED), a Defense agency, for $10,262.00 over a 12-month period. The contract was awarded to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, and other applications to support federal agencies' biomedical research, public health, and healthcare...
This federal contract award to Qiagen, LLC, a subsidiary of Qiagen N.V., was issued by the U.S. Navy Bureau of Medicine and Surgery (BUMED) on July 27, 2015. The contract, valued at $77,151.94, is a blanket purchase agreement (BPA) call for SANDI laboratory supplies. The contract does not have a set-aside designation. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. The company has provided a range of products...
This is a federal purchase order contract award to Qiagen, LLC, a division of Qiagen N.V., by the U.S. Department of Defense's Bureau of Medicine and Surgery. The contract is for the purchase of QIAAMP DNA BLOOD KIT, 200UL and EZ1 DNA TISSUE KIT, 200UL at a firm fixed price of $102,022.09. The award date was July 27, 2015, and the ultimate completion date is August 1, 2016. This contract has no set-aside designation. Qiagen is an international provider of sample and assay technologies that has...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
This federal contract award from the Defense Health Agency (DHA) is for the procurement of EZ1 DNA BLOOD 350 UL KIT TO PURIFY BLOOD, a product offered by Qiagen, LLC, a foreign-owned, for-profit manufacturer. The $39,770.00 firm fixed-price purchase order does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has an extensive portfolio of federal contract awards and grant activities supporting biomedical research, public...
The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Qiagen, LLC, a division of the international medical diagnostics company Qiagen N.V. The contract, valued at $80,457.60, is for the supply of various QIAGEN laboratory supplies including DNA/RNA extraction kits, PCR reagents, and related equipment. This contract was awarded under an unrestricted solicitation and did not have a set-aside designation. Qiagen, as a manufacturer of these specialized...
The Defense Health Agency awarded Qiagen Sciences LLC, a subsidiary of Qiagen N.V., a $11,310.40 firm fixed-price purchase order for the delivery of Deoxyribonucleic Acid (DNA) Organ Transplant Kits. This award was issued on December 27, 2023, with a final completion date of August 19, 2024. The contract has no set-aside designation, indicating Qiagen Sciences LLC was selected as the prime contractor without a preference for small businesses or other socioeconomic categories. Qiagen Sciences LLC...